Delisting risk
Tenaya Therapeutics
Develops gene therapies and small molecules for genetically defined heart diseases.
$0.6956
After-hours close+0.00 (+0.40%)
At close$0.6928(−0.35%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.11 | — | — |
| Aug 2026 | −$0.07 | −$0.20 | −192.7% |
| May 2026 | −$0.09 | −$0.09 | 0.0% |
| Mar 2026 | −$0.13 | −$0.12 | +7.7% |
| Nov 2025 | −$0.15 | −$0.12 | +20.0% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| Jul 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.11 | — | — | $802.5K | — | — |
| Aug 5, 2026 | −$0.07 | −$0.20 | −192.7% | $10.0M | $1.1M | −88.9% |
| May 6, 2026 | −$0.09 | −$0.09 | 0.0% | $7.5M | $225.0K | −97.0% |
| Mar 11, 2026 | −$0.13 | −$0.12 | +7.7% | $3.0M | — | — |
| Nov 10, 2025 | −$0.15 | −$0.12 | +20.0% | — | — | — |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 7, 2025 | ||||||
| Mar 10, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 14, 2024 | ||||||
| Mar 18, 2024 | ||||||
| Nov 8, 2023 | ||||||
| Aug 9, 2023 | ||||||
| May 10, 2023 | ||||||
| Mar 8, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 10, 2022 | ||||||
| May 11, 2022 | ||||||
| Mar 23, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Sep 8, 2021 | ||||||
| Jul 30, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||